Although the growth rates coming out of the quantum computing segment look genuinely spectacular on paper, Wall Street has stood on this exact ledge before, and the fall has never been gentle.
3D Systems Corporation (DDD) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
the company's inability to generate positive free cash flow, which reached -9.7% in 2026Q1, combined with a persistent operating loss, suggests significant ongoing execution risk.
3D Systems Corporation (DDD) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
3D Systems Corporation (DDD) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 11, 2026 | $0.01vs $0.09+88.9% | $96Mvs $92M+3.4% |
| Q2 2026 | Mar 9, 2026 | $0.13vs $0.11-18.2% | $106Mvs $98M+8.5% |
| Q4 2025 | Nov 4, 2025 | $0.08vs $0.09+11.1% | $91Mvs $98M-6.9% |
| Q3 2025 | Aug 11, 2025 | $0.07vs $0.13+46.2% | $95Mvs $98M-2.9% |
Recent stock market news and headlines for 3D Systems Corporation (DDD)
Although the growth rates coming out of the quantum computing segment look genuinely spectacular on paper, Wall Street has stood on this exact ledge before, and the fall has never been gentle.
BOCA RATON, Fla.--(BUSINESS WIRE)-- #FDAClearance--SurGenTec®, a medical device company focused on advancing treatment options for orthopedic and spine surgery, today announced FDA clearance of its ION-L™ Lumbar Facet Fixation System. ION-L™, part of SurGenTec's facet fixation platform, is indicated for the treatment of patients with degenerative disc disease (DDD) from L3 to S1 in skeletally mature patients who have failed conservative care. This clearance is supported by compelling long-term clinical evidenc.

Key metrics vs top competitors for 3D Systems Corporation (DDD)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $2.87 | $421.74M | 15.11 | -12.09% | 7.72% | 14.21% | — | |
| $8.21 | $707.48M | -6.41 | -3.73% | -21.01% | -13.44% | — | |
| $1.46 | $305.44M | -1.07 | 77.3% | -286.76% | -58.69% | — | |
| $7.04 | $415.83M | 47.39 | -3.63% | 3.72% | 4.11% | — | |
| $93.10 | $4.69B | -76.31 | 25.87% | -7.01% | -18.81% | — | |
| $158.00 | $82.41B | 26.33 | 1.52% | 11.14% | 65.25% | — |
3D Systems Corporation (DDD) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
3D Systems Corporation (DDD) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 15, 2026·SEC
May 11, 2026·SEC
Apr 30, 2026·SEC
Get notified when DDD posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
3D Systems Corporation (DDD) stock FAQ — growth, dividends, profitability & financials explained
3D Systems Corporation (DDD) reported $387.9M in revenue for fiscal year 2025. This represents a 387% increase from $79.6M in 1996.
3D Systems Corporation (DDD) saw revenue decline by 12.1% over the past year.
Yes, 3D Systems Corporation (DDD) is profitable, generating $62.4M in net income for fiscal year 2025 (7.7% net margin).
3D Systems Corporation (DDD) has a return on equity (ROE) of 14.2%. This is reasonable for most industries.
3D Systems Corporation (DDD) had negative free cash flow of $70.5M in fiscal year 2025, likely due to heavy capital investments.